Cell Therapy Center, The University of Jordan, Amman, Jordan; Clinical Laboratory Sciences Department, School of Science, The University of Jordan, Amman, Jordan.
Cell Therapy Center, The University of Jordan, Amman, Jordan.
Can J Ophthalmol. 2019 Feb;54(1):51-59. doi: 10.1016/j.jcjo.2018.02.018. Epub 2018 Apr 10.
To identify the disease-causing variants in 2 families with autosomal recessive inherited retinal dystrophies (IRDs) and to characterize phenotypic variability across the affected family members.
Exome sequencing and ophthalmic clinical examination study.
Six members from 2 consanguineous Jordanian families with IRD.
Ophthalmic examinations and whole-exome sequencing (WES) were performed to identify IRD-causing variants in affected individuals from each family, followed by segregation analysis of candidate variants in affected and unaffected family members by Sanger sequencing.
We identified 2 different homozygous deletion variants in CERKL in each family: a novel pathogenic variant, c.450_451delAT, and a known variant, c.1187_1188delTG. Both variants co-segregated with the disease in all affected family members. The resulting phenotypes further supported that CERKL is associated with cone-rod dystrophy (CRD) rather than retinitis pigmentosa (RP), as originally established.
Our study expands the genotypic spectra of CERKL variants, providing insights into the relevant pathogenesis of RP/CRD. We also confirm that the WES approach is a valuable tool for the molecular diagnosis of retinopathies.
鉴定 2 个常染色体隐性遗传视网膜疾病(IRDs)家系的致病变异,并对受影响家族成员的表型变异性进行特征描述。
外显子组测序和眼科临床检查研究。
2 个有 IRD 的约旦近亲家系的 6 名成员。
对每个家系的受影响个体进行眼科检查和全外显子组测序(WES),以鉴定导致 IRD 的变异,然后通过 Sanger 测序对候选变异在受影响和未受影响的家系成员中的进行分离分析。
我们在每个家系中都鉴定到了 CERKL 的 2 个不同的纯合缺失变异:一个新的致病变异 c.450_451delAT 和一个已知的变异 c.1187_1188delTG。这两种变异都与所有受影响的家族成员中的疾病共分离。进一步的表型结果支持 CERKL 与 cone-rod dystrophy(CRD)相关,而不是最初确定的 retinitis pigmentosa(RP)。
我们的研究扩展了 CERKL 变异的基因型谱,为 RP/CRD 的相关发病机制提供了深入了解。我们还证实 WES 方法是视网膜病变分子诊断的有价值的工具。